Interim results from a phase I/II study of duvelisib PI3Kdg inhibitor and nivolumab in patients with advanced unresectable melanoma who have progressed on anti-PD1 therapy.
Duvelisib;Nivolumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Interim results from a phase I/II study of duvelisib PI3Kdg inhibitor and nivolumab in patients with advanced unresectable melanoma who have progressed on anti-PD1 therapy. ### Output: Duvelisib;Nivolumab